Liesbeth Ruijgrok

Liesbeth Ruijgrok serves as a Researcher within the Pharmacy department at Erasmus University Medical Center (Erasmus MC) in Rotterdam, Netherlands. Her academic work bridges pharmaceutical science with clinical applications, focusing on optimizing drug therapies for complex medical conditions through rigorous translational research.

Her primary research spans Pharmacology, Toxicology, and Pharmaceutical Sciences with specialized expertise in Adrenal Insufficiency management, Preeclampsia pathophysiology, Drug-Drug Interactions, and advanced Drug Delivery Systems. She pioneers innovative approaches including pharmaceutical 3D printing for personalized hydrocortisone formulations, functional respiratory imaging for aerosol deposition analysis in pediatric asthma, and mechanistic studies of statins in hypertensive pregnancy disorders. Her work consistently addresses critical therapeutic challenges in pharmacokinetics and pharmacodynamics.

Analysis of her 2024 publications reveals a strong trend toward solving real-world pharmacotherapy problems through technological innovation and mechanistic understanding. Key themes include cost-effective manufacturing of personalized medicines, precision drug delivery for respiratory diseases, and repurposing existing drugs for novel indications like preeclampsia. Her collaborative studies frequently integrate clinical data with pharmaceutical technology to enhance therapeutic outcomes.

No scientific awards were documented in the available profile information.

No details regarding student mentorship, research grant funding, or laboratory infrastructure were provided in the source materials. Her research appears to be conducted through multidisciplinary collaborations within Erasmus MC's clinical departments rather than a dedicated independent laboratory.